Development of a cell-based medicinal product: regulatory structures in the European Union.

Development of a cell-based medicinal product: regulatory structures in the European Union.

Item
http://www.wikidata.org/entity/Q38062899
EGF-induced adipose tissue mesothelial cells undergo functional vascular smooth muscle differentiation.Adaptation through Collaboration: Developing Novel Platforms to Advance the Delivery of Advanced Therapies to Patients.Deterministic and stochastic approaches in the clinical application of mesenchymal stromal cells (MSCs).Are there specific translational challenges in regenerative medicine? Lessons from other fields.Standard requirement of a microbiological quality control program for the manufacture of human mesenchymal stem cells for clinical use.Enhancing effect of glucose microspheres in the viability of human mesenchymal stem cell suspensions for clinical administration.Regulatory Considerations for Gene Therapy Products in the US, EU, and Japan.[Advanced medicinal products medical therapy based on mesenchymal stem cells].
P2860

Development of a cell-based medicinal product: regulatory structures in the European Union.

Item
http://www.wikidata.org/entity/Q38062899
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Development of a cell-based me ...... uctures in the European Union.
@en
type
label
Development of a cell-based me ...... uctures in the European Union.
@en
prefLabel
Development of a cell-based me ...... uctures in the European Union.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P478
P577
P5875
P698
P356
P1433
P1476
Development of a cell-based me ...... uctures in the European Union.
@en
P2093
P2860
P304
P31
P356
P478
P577
P5875
P698